Comparison of the [F]-FDG and [F]-FLT PET Tracers in the Evaluation of the Preclinical Proton Therapy Response in Hepatocellular Carcinoma.

Fiche publication

Date publication

avril 2021

Journal

Molecular imaging and biology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr BRASSE David , Pr LAQUERRIERE Patrice , Dr BURCKEL Hélène , Dr FINCK Christian

Tous les auteurs :
Brasse D, Burckel H, Marchand P, Rousseau M, Ouadi A, Vanstalle M, Finck C, Laquerriere P, Boisson F

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/33847900

Résumé

The main objective of the present study was to compare the 2-deoxy-2-[F]fluoro-D-glucose ([F]-FDG) and 3'-[F]fluoro-3'-deoxythymidine ([F]-FLT) PET imaging biomarkers for the longitudinal follow-up of small animal proton therapy studies in the context of hepatocellular carcinoma (HCC).